ArticleCureus2026
Aberrant CD4 Expression in Plasma Cell Myeloma With Unusual Morphology: A Rare Diagnostic Pitfall.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plasma cell myeloma (PCM) is a clonal plasma cell neoplasm diagnosed by its characteristic morphology and immunophenotype. Rarely, it shows significant morphological and immunophenotypic heterogeneity, mimicking other hematolymphoid malignancies. This case highlights PCM with deceptive morphology and aberrant T-cell marker expression, underscoring a key diagnostic pitfall. A 62-year-old female presented with an indurated lesion on the left lateral aspect of the tongue and left shoulder swelling for one month, with associated constitutional symptoms. Laboratory investigations showed anemia, raised lactate dehydrogenase, serum creatinine, and serum calcium levels. Biopsy from both sites revealed a neoplasm composed of small- to medium-sized cells in diffuse sheets with mild nuclear pleomorphism. Immunohistochemistry done on the tongue lesion revealed positivity for CD138, CD38, light chain kappa, and CD4, with a Ki-67 index of 90%. A similar immunohistochemical profile was identified in the shoulder lesion. Both lesions were diagnosed as plasmacytoma, prompting evaluation for PCM. Imaging demonstrated an enhancing soft tissue density on the anterior half of the tongue, multiple sclerotic and lytic lesions, multiple metastatic lymph nodes, and multiple nodular deposits in the cervical region. Subsequent bone marrow examination revealed 90% marrow plasmacytosis with kappa light chain restriction, confirmed by immunohistochemistry. This concluded in a final diagnosis of PCM with kappa light chain restriction and aberrant CD4 positivity. The diagnosis was corroborated with further myeloma workup, which revealed an M band in serum electrophoresis, markedly elevated serum kappa free light chain, kappa:lambda ratio, and serum IgG. Diagnosis of PCM becomes challenging in atypical presentations, lacking classical morphology and immunophenotype, necessitating a comprehensive immunohistochemical panel and close clinicopathological correlation while accounting for lineage infidelity in poorly differentiated hematologic neoplasms to avoid diagnostic pitfalls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.